Santhera Pharmaceuticals Holding AG (XSWX:SANN) Buildings And Improvements : CHF7.82 Mil (As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Buildings And Improvements?

Santhera Pharmaceuticals Holding AG's quarterly buildings and improvements declined from Dec. 2023 (CHF5.35 Mil) to Jun. 2024 (CHF0.00 Mil) but then increased from Jun. 2024 (CHF0.00 Mil) to Dec. 2024 (CHF7.82 Mil).

Santhera Pharmaceuticals Holding AG's annual buildings and improvements increased from Dec. 2022 (CHF5.28 Mil) to Dec. 2023 (CHF5.35 Mil) and increased from Dec. 2023 (CHF5.35 Mil) to Dec. 2024 (CHF7.82 Mil).

Santhera Pharmaceuticals Holding AG Buildings And Improvements Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Buildings And Improvements Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

5.88

5.79

5.28

5.35

7.82

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial															5.28	-	5.35	-	7.82

Santhera Pharmaceuticals Holding AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Santhera Pharmaceuticals Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

SPHDF:USA SANNz:UK 0QN1:UK S3F0:Germany

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives the majority of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG Headlines

No Headlines